Writing a Research Summary / Lay Summary
As for all of your proposal writing, the research summary should be written clearly and in simple terms. The assessors reading your proposal may not be experts in your field. Additionally, it is likely that your assessors will have a stack of applications to review, and not much time to review them. It is vital that the assessor can quickly and easily grasp not only what it is you would like to be funded, and why it is so exciting, novel and innovative.
It is a good idea to write the summary after you have written the rest of your proposal. You may modify your approach as you develop your proposal. By writing the summary when you have completed your application, you can be sure that you are including the most up to date information.
To write a really strong summary you will need to address the following questions:
- Why is the project important, needed and timely?
- How is the proposed approach special and exciting?
- Why should you be doing the research?
- What will the outcome of the project be?
- How does your research fit the funder and call?
- How will this research be of such enormous benefit?
- What will the impact of your research be?
- How will this impact be achieved?
You can access a previous blog post on writing an excellent lay summary here: Writing a Lay Summary is Easy, Right?











REF mock exercise 2026 – nominate your research outputs on BRIAN
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
First publication for two CMWH PhD students
SPROUT Returns: Designing Sustainability in Research Practice – Wednesday 20 May 12-2pm
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease